What can nuclear medicine do for cancer research? Quite a lot, says PRecirix CTO Dimitrios Mantzilas | Talking RadioPharma Series

‘I’ve always been curious,’ Precirix Chief Technology Officer Dimitrios Mantzilas admits. It’s certainly served him well in his career in nuclear medicine. Matthew Palmer, Senior Oncology Consultant for our Life Sciences team, spoke to Dimitrios for this episode of the Venari Podcast’s Talking Radiopharma series. But what did we learn from their conversation?